SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Conmed Corp – ‘8-K’ for 11/21/19

On:  Thursday, 11/21/19, at 2:27pm ET   ·   For:  11/21/19   ·   Accession #:  1174947-19-1223   ·   File #:  0-16093

Previous ‘8-K’:  ‘8-K’ on / for 10/30/19   ·   Next:  ‘8-K’ on / for 1/29/20   ·   Latest:  ‘8-K’ on 2/27/24 for 2/26/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/21/19  Conmed Corp                       8-K:8      11/21/19   10:179K                                   Computershare C… Svcs/FA

Current Report   —   Form 8-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     25K 
 6: R1          Cover                                               HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 9: XML         XBRL Instance -- form8k-23069_cnmd_htm               XML     14K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.LAB  XBRL Labels -- cnmd-20191121_lab                     XML     96K 
 4: EX-101.PRE  XBRL Presentations -- cnmd-20191121_pre              XML     64K 
 2: EX-101.SCH  XBRL Schema -- cnmd-20191121                         XSD     12K 
 5: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
10: ZIP         XBRL Zipped Folder -- 0001174947-19-001223-xbrl      Zip     10K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C:   C:   C:   C:   C:   C: 
 i 0000816956  i false 0000816956 2019-11-21 2019-11-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

 

FORM  i 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15 (d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

Date of Report (Date of earliest event reported):  i November 21, 2019

 

 

 i CONMED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 i New York  i 0-16093  i 16-0977505
(State or other jurisdiction of (Commission (I.R.S. Employer
incorporation or organization) File Number) Identification No.)

 

 i 525 French Road

 i Utica,  i New York  i 13502

(Address of principal executive offices, including zip code)

 

 

 i (315)  i 797-8375

(Registrant's telephone number, including area code)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

 

 i           Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i           Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i           Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i           Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
 i Common Stock, $0.01 par value  i CNMD  i NASDAQ

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 C: 

 

 

 

Item 8.01 Other Events

 

On November 21, 2019, CONMED Corporation announced it will be paying a quarterly cash dividend of $0.20 per share on January 7, 2020 to all shareholders of record as of December 13, 2019.

 

 C: 

 

 

 

 

 

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

     
Date:     November 21, 2019   CONMED CORPORATION
    (Registrant)
     
     
  By: /s/  Todd W. Garner
  Name: Todd W. Garner
  Title: Executive Vice President-
    Chief Financial Officer

 

 C: 

 

 

 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
1/7/20
12/13/194
Filed on / For Period end:11/21/19
 List all Filings 
Top
Filing Submission 0001174947-19-001223   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 2:23:46.1am ET